Reference

1. Baichwal RS. Developments in nutraceuticals. Pharm Times 1999;  1: 19-20.  
2. Kalra EK. Nutraceutical – Definition and introduction. AAPS Pharm Sci. 2003;5:E25.   [PMC free article] [PubMed] [Google Scholar  
3. Chauhan B, Kumar G, Kalam N, Ansari SH. Current concepts and prospects of herbal nutraceutical: A review. J Adv Pharm Technol Res. 2013;4:4–8. [PMC free article] [PubMed] [Google Scholar]  
4. Hardy G. Nutraceuticals and functional foods: Introduction and meaning. Nutrition.  2000;16:688–9. [PubMed] [Google Scholar]  
5. Elia Ranzato1, Simona Martinotti1 , Cinzia Myriam Calabrese2,"Role of Nutraceuticals in Cancer Therapy Journal of Food Research"; Vol. 3, No. 4; 2014  ISSN 1927-0887 E-ISSN 

1927-0895 Published by Canadian Center of Science and Education  

6. Roudebush P, D. J. Davenport, B. J. Novotny:The use of nutraceuticals in cancer therapy.   Vet Clin North Am Small Anim Pract34(1), 249-69 (2004)  
7. Adams BK, E. M. Ferstl, M. C. Davis, M. Herold, S.Kurtkaya, R. F. Camalier, M. G. Hollingshead, G. Kaur, E.A. Sausville, F. R. Rickles, J.P. Snyder, D. C. Liotta & M Shoji: Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and antiangiogenesis agents. Bioorg Med Chem. 12(14):3871-3883 (2004)  
8. Galati G & P.J. O'Brien: Cytoprotective and anticancer properties of coenzyme Q versus capsaicin.Biofactors.18(1-4):195-205 (2003)  
9. Moyers SB 7 N. B. Kumar: Green tea polyphenols and cancer chemoprevention: multiple mechanisms and endpoints for phase II trials. Nutr Rev. 62(5):204-211 (2004)  
10. Surh YJ, K. K. Park, K. S. Chun, L. J. Lee, E. Lee & S.S. Lee: Anti-tumor-promoting activities of selected pungent phenolic substances present in ginger., J Environ Pathol Toxicol Oncol.18(2):131139 (1999)  
11. Bemis DL, J.L. Capodice, M. Desai, R. Buttyan & A.E. Katz : A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Clin Cancer Res. 10(15), 5282-5292 (2004)  
12. Laux MT, M. Aregullin, J.P. Berry, J. A. Flanders & E.Rodriguez: Identification of a p53dependent pathway in The induction of apoptosis of human breast cancer cells by The natural product, resveratrol. J Altern Complement Med. Apr;10(2):235-239 (2004)  
13. McEleny K, R. Coffey, C. Morrissey, J.M. Fitzpatrick & R.W. Watson: Caffeic acid phenethyl ester-induced PC-3 Cell apoptosis is caspase-dependent and mediated through The loss of inhibitors of apoptosis proteins, BJU Int. 94(3):402-406 (2004)  
14. Parnaud G, P. Li, G. Cassar, P. Rouimi, J. Tulliez, L. Combaret, L. Gamet-Payrastre: Mechanism of Sulforaphane-Induced Cell Cycle Arrest and Apoptosis in Human Colon Cancer Cells.Nutr Cancer. 48(2):198-206 (2004)  
15. Kristal AR, J.L. Stanford: Cruciferous vegetables and Prostate cancer risk: confounding by PSA screening. Cancer Epidemiol Biomarkers Prev. 13(7):1265-1269 (2004)  
16. Singh RP, R. Agarwal : Prostate cancer prevention by Silibinin. Curr Cancer Drug Targets.  4(1):1-11 (2004)  
17. Martarelli D, B. Martarelli, D. Pediconi, M.I. Nabissi, M. Perfumi & P. Pompei: Hypericum perforatum Methanolic extract inhibits growth of human prostatic Carcinoma cell line  orthotopically implanted in nude mice. Cancer Lett. 210(1):27-33 (2004)  
18. Anderton MJ, M. M. Manson, R. D. Verschoyle, A. Gescher, J.H. Lamb, P.B. Farmer, W.   P. Steward & M.L. Williams:, Pharmacokinetics and tissue disposition of Indole-3-carbinol and its acid condensation products after Oral administration to mmice Clin Cancer Res.  10(15):5233-5241 (2004)  
19. Pan MH, W.J. Chen, S.Y. Lin-Shiau, C.T. Ho & J. K. Lin: Tangeretin induces cell-cycle G1 arrest through Inhibiting cyclin-dependent kinases 2 and 4 activities as Well as elevating Cdk inhibitors p21 and p27 in human Colorectal carcinoma cells. Carcinogenesis. 23(10), 1677- 1684 (2002)  
20. Zhang S, X. Yang, M.E. Morris:, Combined effects of Multiple flavonoids on breast cancer resistance protein (ABCG2)-mediated transport. Pharm Res. 21(7):1263-1273 (2004)  
21. Oommen S, R.J. Anto, G. Srinivas & D. Karunagaran: Allicin (from garlic) induces caspasemediated apoptosis in Cancer cells. Eur J Pharmacol. 485(1-3):97-103 (2004)33.  
22. Chalabi N, L. Le Corre, J. C. Maurizis, Y. J. Bignon & D. J. Bernard-Gallon: The effects of lycopene on the Proliferation of human breast cells and BRCA1 and BRCA2 gene expression. Eur J Cancer. 40(11), 1768-1775 (2004)  
23. Huang Q, H. M. Shen & C. N. Ong: Inhibitory effect of Emodin on tumor invasion through suppression of activator Protein-1 and nuclear factor-kappaB. Biochem Pharmacol. 68(2):361-371 (2004)  
24. Tapiero H, D. M. Townsend &K. D. Tew: Organosulfur Compounds from alliaceae in the prevention of human Pathologies. Biomed Pharmacother. 58(3):183-193 (2004)  
25. Hiipakka RA, H.Z. Zhang, W. Dai, Q. Dai & S. Liao: Structure-activity relationships for inhibition of human 5alpha-reductases by polyphenols. Biochem Pharmacol. 63(6):11651176 (2002)  
26. Reddy  BS:Chemoprevention  of  colon cancer by dietary Administration of naturally occurring and related synthetic Agents. Adv Exp Med Biol. 400B, 931-936 (1997)  
27. Palozza P, S. Serini, F. Di Nicuolo & G. Calviello,Modulation of apoptotic signalling by carotenoids In cancer cells. Arch Biochem Biophys. 430(1):104-109 (2004)  
28. Krishnan Sathishkumar et al. Indian J Med Res. 2022 Oct-Nov  
29. Kim, C.; Kim, K. Anti-Cancer Natural Products and Their Bioactive Compounds Inducing   ER Stress-Mediated Apoptosis: A Review. Nutrients 2018, 10, 1021. [CrossRef]  
30. Hardy G. Nutraceuticals and functional foods: Introduction and meaning. Nutrition. 2000;16:688–9. [PubMed] [Google Scholar]  
31. Moradian S, Howell D. (2015). Prevention and management of chemotherapy-induced nausea and vomiting. Int J Palliat Nurs, 21(5):216, 218–24. [PubMed] [Google Scholar]  
32. Mhd Anas Tomeh,Roja Hadianamrei :"A Review of Curcumin and Its Derivatives as Anticancer Agents" Int J Mol Sci.Mar2019  
33. Dijsselbloem N, W. Vanden Berghe, A. De Naeyer & G. Haegeman.:Soy isoflavone phyto pharmaceuticals in interleukin-6 affections; Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapy. Biochem Pharmacol. ;68(6),1171-85 (2004)  
34. Gupta S., Chauhan D., Mehla K., Sood P., Nair A. An overview of nutraceuticals: Current scenario. J. Basic Clin. Pharm. 2010;1:55–62. [PMC free article] [PubMed] [Google  Scholar]  
35. See D, S. Mason & R. Roshan: Increased tumor Necrosis factor alpha (TNF-alpha) and natural killer cell (NK) function using an integrative approach in late stage Cancers., Immunol Invest. 31(2):137-153 (2002)  
36. J.S. Jurenka, Anti-inflammatory properties of curcumin, a major constituent of  Curcuma longa: a review of preclinical and clinical research, Alternative  Medicine review 14 (2) (2009)  
37. R. Wilken, M.S. Veena, M.B. Wang, E.S. Srivatsan, Curcumin: A review of anticancer properties and therapeutic activity in head and neck squamous cell  Carcinoma, Molecular  cancer 10 (1) (2011) 12.  
38. Goel, A.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin as “Curecumin”: From kitchen to clinic. Biochem. Pharm. 2008, 75, 787–809. [CrossRef] [PubMed]  
39. Anand, P.; Sundaram, C.; Jhurani, S.; Kunnumakkara, A.B.; Aggarwal, B.B. Curcumin and cancer: An “old-age” disease with an “age-old” solution. Cancer Lett. 2008, 267, 133– 164. [CrossRef] [PubMed]  
40. Nagahama, K.; Utsumi, T.; Kumano, T.; Maekawa, S.; Oyama, N.; Kawakami, J. Discovery of a new function Of curcumin which enhances its anticancer therapeutic potency. Sci. Rep. 2016, 6, 30962. [CrossRef] [PubMed]  
41. Kunnumakkara, A.B.; Bordoloi, D.; Padmavathi, G.; Monisha, J.; Roy, N.K.; Prasad, S.; Aggarwal, B.B. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic diseases. Br. J. Pharm. 2017, 174, 1325–1348. [CrossRef] [PubMed]  
42. Negrini, S.; Gorgoulis, V.; Halazonetis, T. Genomic instability—An evolving hallmark of cancer. Nat. Rev. Mol. Cell Biol. 2010, 11, 220–228. [CrossRef] [PubMed]  
43. Mohamed, S.I.A.; Jantan, I.; Haque, M.A. Naturally occurring immunomodulators with antitumor activity: An insight on their mechanisms of action. Int. Immunopharmacol. 2017, 50, 291–304. [CrossRef]  
44. Schieber, M.; Chandel, N.S. ROS function in redox signaling and oxidative stress. Curr.  Biol. 2014, 24, 453–462. [CrossRef]  
45. Nakamae, I.; Morimoto, T.; Shima, H.; Shionyu, M.; Fujiki, H.; Yoneda-Kato, N.; Yokoyama, T.; Kanaya, S.; Kakiuchi, K.; Shirai, T.; et al. Curcumin Derivatives Verify the  Essentiality of ROS Upregulation in Tumor Suppression. Molecules 2019, 24, 4067.[CrossRef]  
46. Sethi, G.; Tergaonkar, V. Potential pharmacological control of the NF-?B pathway. Trends  Pharmacol. Sci. 2009, 30, 313–321. [CrossRef]  
47. Ghasemi, F.; Shafiee, M.; Banikazemi, Z.; Pourhanifeh, M.H.; Khanbabaei, H.; Shamshirian, A.; Amiri-Moghadam, S.; ArefNezhad, R.; Sahebkar, A.; Avan, A.; et al.  

Curcumin inhibits NF-kB and Wnt/?-catenin pathways in cervical cancer cells. Pathol. Res. Pract.2019, 215, 152556. [CrossRef] [PubMed]  

48. Iqbal, B.; Ghildiyal, A.; Singh, S.; Siddiqui, S.; Kumari, P.; Arshad, M.; Mahdi, A. A Combinatorial effect of curcumin and tumor necrosis factor-?-related apoptosis-inducing ligand (TRAIL) in induction of apoptosis via inhibition of nuclear factor kappa activity and enhancement of caspase3 activity in chronic myeloid cells: An in-vitro study. J. Cancer Res. Ther. 2018, 14, 1193–1200.  
49. Das, L.; Vinayak, M. Curcumin Modulates Glycolytic Metabolism and Inflammatory   Cytokines via Nrf 2 in Dalton’s Lymphoma Ascites Cells In Vivo. Anticancer Agents Med. Chem. 2018, 18, 1779–1791. [CrossRef] [PubMed]  
50. Kunnumakkara, A.B.; Bordoloi, D.; Padmavathi, G.; Monisha, J.; Roy, N.K.; Prasad, S.; Aggarwal, B.B. Curcumin, the golden nutraceutical: Multitargeting for multiple chronic  diseases. Br. J. Pharmacol. 2017, 174, 1325–1348. [CrossRef] [PubMed]  
51. . Yu, Y.; Shen, Q.; Lai, Y.; Park, S.Y.; Ou, X.; Lin, D.; Jin, M.; Zhang, W. Antiinflammatory Effects of Curcumin in Microglial Cells. Front Pharmacol. 2018, 9, 386. [CrossRef]  
52. Srivastava, N.S.; Srivastava, R.A.K. Curcumin and quercetin synergistically inhibit cancer cell proliferation in multiple cancer Cells and modulate Wnt/?-catenin signaling and apoptotic pathways in A375 cells. Phytomedicine 2019, 52, 117–128. [CrossRef]  [PubMed]  
53. Berman, A. Y., Motechin, R. A., Wiesenfeld, M. Y., and Holz, M. K. (2017). The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis. Oncol. 1:35. doi:   10.1038/s41698-017-0038-6  
54. Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., et al. (2006). Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337–  342. Doi: 10.1038/nature05354  
55. Aggarwal, B.B.; Bhardwaj, A.; Aggarwal, R.S.; Seeram, N.P.; Shishodia, S.; Takada, Y. Role of resveratrol In prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res. 2004, 24, 2783–2840. [PubMed]  
56. Bishayee, A. Cancer prevention and treatment with resveratrol: From rodent studies to clinical trials. Cancer Prev. Res. 2009, 2, 409–418. [CrossRef] [PubMed]  
57. Leonard, S.S.; Xia, C.; Jiang, B.H.; Stinefelt, B.; Klandorf, H.; Harris, G.K.; Shi, X. Resveratrol scavenges Reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun. 2003,309, 1017–1026. [CrossRef] [PubMed]  
58. Khansari, N.; Shakiba, Y.; Mahmoudi, M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat. Inflamm. Allergy Drug Discov. 2009, 3, 73– 80. [CrossRef] [PubMed]  
59. Barzilai, A.; Yamamoto, K. DNA damage responses to oxidative stress. DNA Repair 2004, 3, 1109–1115. [CrossRef] [PubMed]  
60. Fruehauf, J.P.; Meyskens, F.L., Jr. Reactive oxygen species: A breath of life or death? Clin. Cancer Res. 2007, 13, 789–794. [CrossRef] [PubMed]  
61. Dorrie, J.; Gerauer, H.; Wachter, Y.; Zunino, S.J. Resveratrol induces extensive apoptosis by depolarizing Mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells. Cancer Res. 2001, 61, 4731–4739. [PubMed].  
62. Ahmad, N.; Adhami, V.M.; Afaq, F.; Feyes, D.K.; Mukhtar, H. Resveratrol causes WAF1/p21mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human   epidermoid carcinoma A431 cells. Clin. Cancer Res. 2001, 7, 1466–1473. [PubMed]  
63. Ferry-Dumazet, H.; Garnier, O.; Mamani-Matsuda, M.; Vercauteren, J.; Belloc, F.; Billiard, C.; Dupouy, M.; Thiolat, D.; Kolb, J.P.; Marit, G.; et al. Resveratrol inhibits the growth and induces the apoptosis of both normal and leukemic hematopoietic cells. Carcinogenesis 2002, 23, 1327– 1333. [CrossRef] [PubMed]  
64. Filippi-Chiela, E.C.; Villodre, E.S.; Zamin, L.L.; Lenz, G. Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS ONE 2011, 6, e20849. [CrossRef] [PubMed]  
65. Liao, P.C.; Ng, L.T.; Lin, L.T.; Richardson, C.D.; Wang, G.H.; Lin, C.C. Resveratrol arrests cell cycle and induces apoptosis in human hepatocellular carcinoma Huh-7 cells. J. Med. Food 2010, 13, 1415–1423. [CrossRef] [PubMed]  
66. Rashid, A.; Liu, C.; Sanli, T.; Tsiani, E.; Singh, G.; Bristow, R.G.; Dayes, I.; Lukka, H.; Wright, J.; Tsakiridis, T. Resveratrol enhances prostate cancer cell response to ionizing radiation. Modulation of the AMPK, Akt and mTOR pathways. Radiat. Oncol. 2011, 6, 144. [CrossRef] [PubMed]  
67. Hsieh, T.C.; Wong, C.; John Bennett, D.; Wu, J.M. Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: An in silico and biochemical approach targeting integrin ?v?3. Int. J. Cancer 2011, 129, 2732–2743. [CrossRef]  [PubMed]  
68. Demin G., Yingying Z. Comparative antibacterial activities of crude polysaccharides and flavonoids from Zingiber officinale and their extraction. American Journal of Tropical Medicine. 2010;5:235–238. [Google Scholar]  
69. Srinivasan K. Antioxidant potential of spices and their active constituents. Critical Reviews in Food Science and Nutrition. 2014;54(3):352–372. Doi:    10.1080/10408398.2011.585525. [PubMed] [CrossRef] [Google Scholar]  
70. Pennathur S., Maitra D., Byun J., Sliskovic I., Abdulhamid I., Saed G.M., Diamond M.P., AbuSoud H.M. Potent antioxidative activity of lycopene: A potential role in scavenging hypochlorous acid. Free Radic. Biol. Med. 2010;49:205–213. Doi:    10.1016/j.freeradbiomed.2010.04.003. [PMC free article] [PubMed] [CrossRef] [Google Scholar]  
71. Yin Y., Zheng Z., Jiang Z. Effects of lycopene on metabolism of glycolipid in type 2 diabetic rats. Biomed. Pharmacother. 2019;109:2070–2077. Doi: 10.1016/j.biopha.2018.07.100. [PubMed] [CrossRef] [Google Scholar]  
72. Ghadage S., Mane K., Agrawal R., Pawar V. Tomato lycopene: Potential health benefits. Pharma Innov. J. 2019;8:1245–1248. [Google Scholar]  
73. Rao A.V., Waseem Z., Agarwal S. Lycopene content of tomatoes and tomato products and their contribution to dietary lycopene. Food Res.Int.1998;31:737–741.doi:10.1016/S09639969(99)00053-8. [CrossRef] [Google Scholar]  
74. Rao A.V., Waseem Z., Agarwal S. Lycopene content of tomatoes and tomato products and their contribution to dietary lycopene. Food Res. Int. 1998;31:737–741.Doi:10.1016/S09639969(99)00053-8. [CrossRef] [Google Scholar]
75. Ghadage S., Mane K., Agrawal R., Pawar V. Tomato lycopene: Potential health benefits.  Pharma Innov. J. 2019;8:1245–1248. [Google Scholar]  
76. Ghadage S., Mane K., Agrawal R., Pawar V. Tomato lycopene: Potential health benefits. Pharma Innov. J. 2019;8:1245–1248. [Google Scholar]  
77. Woodside J.V., McGrath A.J., Lyner N., McKinley M.C. Carotenoids and health in older people. Maturitas.2015;80:63–68.doi:10.1016/j.maturitas.2014.10.012.[PubMed][Google Scholar]  
78. X.Jiang, H.Wu,W. Zhao, X.Ding, Q. You, F. Zhu, M. Qian, P. Yu Lycopene improves the efficiency of anti-PD-1 therapy via activating IFN signaling of lung cancer cells Cancer Cell Int., 19 (1) (2019), pp. 1-12, 10.1186/S12935-019-0789-Y/FIGURES/6 Google Scholar  
79. X. Chen, G. Yang, M. Liu, Z. Quan, L. Wang, C. Luo, X. Wu, Y. Zheng Lycopene enhances the sensitivity   of         castration-resistant prostate    cancer            613(2022),pp.53-60, 10.1016/J.BBRC.2022.04.126.Google Scholar
80. P. PANDEY, F. KHAN, A mechanistic review of the anticancer potential of hesperidin, a natural flavonoid from citrus fruits, Nutr. Res. 92 (2021) 21–31.  
81. B.P. Puah, J. Jalil, A. Attiq, Y. Kamisah, New insights into molecular mechanism behind anticancer activities of lycopene, Molecules 26 (13) (2021)   3888,10.3390/molecules26133888. PMID: 34202203; PMCID: PMC8270321.  
82. Zhao T., Li C., Wang S., Song X. Green Tea (Camellia sinensis): A Review of Its  Phytochemistry, Pharmacology, and Toxicology. Molecules. 2022;27:3909. doi:  

10.3390/molecules27123909. [PMC free article] [PubMed] [CrossRef] [Google Scholar

83. De Amicis F., Russo A., Avena P., Santoro M., Vivacqua A., Bonofiglio D., Mauro L.,   Aquila S., Tramontano D., Fuqua S.A., et al. In vitro mechanism for downregulation of   ER-? expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells. Mol. 

Nutr. Food Res. 2013;57:840–853. doi: 10.1002/mnfr.201200560. [PMC free article] [PubMed] [CrossRef] [Google Scholar]  

84. Almatroodi S.A., Almatroudi A., Khan A.A., Alhumaydhi F.A., Alsahli M.A., Rahmani 

A.H. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most   Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.  

Molecules. 2020;25:3146. doi: 10.3390/molecules25143146. [PMC free article] [PubMed] [CrossRef] [Google Scholar]  

85. Farhan M. Green Tea Catechins: Nature’s Way of Preventing and Treating Cancer. Int. J. Mol. Sci. 2022;23:10713. doi: 10.3390/ijms231810713. [PMC free article] [PubMed]  [CrossRef] [Google Scholar]  
86. Gupta, S.; Hussain, T.; Mukhtar, H. Molecular pathway for (?)-epigallocatechin-3gallateinduced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch.   Biochem. Biophys. 2003, 410, 177–185. [Google Scholar] [CrossRef]  
87. Mayr, C.; Wagner, A.; Neureiter, D.; Pichler, M.; Jakab, M.; Illig, R.; Berr, F.; Kiesslich, T. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells. BMC Complement. Altern. Med 2015, 15, 194. [Google Scholar] [CrossRef] [PubMed][Green Version]
88. Hussain, T.; Gupta, S.; Adhami, V.M.; Mukhtar, H. Green tea constituent epigallocatechin3gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells. Int. J. Cancer 2004, 113, 660–669. [Google Scholar] [CrossRef]  
89. Oommen, S., Anto, R. J., Srinivas, G., and Karunagaran, D. (2004). Allicin (From Garlic)  Induces Caspase-Mediated Apoptosis in Cancer Cells. Eur. J. Pharmacol. 485 (1), 97–103. Doi:10.1016/j.ejphar.2003.11.059 PubMed Abstract | CrossRef Full Text | Google Scholar 
90. Miron, T., Wilchek, M., Sharp, A., Nakagawa, Y., Naoi, M., Nozawa, Y., et al. (2008).  Allicin Inhibits Cell Growth and Induces Apoptosis through the Mitochondrial Pathway in  HL60 and U937 Cells. J.Nutr.Biochem.19 (8),524–535 Doi:10.1016/j.jnutbio.2007.06.009    
91. Yang, D., Lv, Z., Zhang, H., Liu, B., Jiang, H., Tan, X., et al. (2017). Activation of the Nrf2 Signaling Pathway Involving KLF9 Plays a Critical Role in Allicin Resisting against Arsenic Trioxide-Induced Hepatotoxicity in Rats. Biol. Trace Elem. Res. 176 (1), 192–200 Doi:10.1007/s12011-016-0821-1 PubMed Abstract | CrossRef Full Text | Google Scholar